(8S,9S,10S,13R,14S,17S)-3-azido-17-ethyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: (8S,9S,10S,13R,14S,17S)-3-azido-17-ethyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene
• 化学式: C21H35N3
• 分子量: 329.5
• InChiKey: RQPHMQSYJUPEDP-PYASFRJRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.3
• 重原子数：
  24
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  14.4
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• [EN] USE OF STEROID-DERIVED PHARMACEUTICAL COMPOSITIONS FOR TREATING DISORDERS RELATING TO PATHOLOGICAL PROCESSES IN LIPID RAFTS<br/>[FR] UTILISATION DE COMPOSITIONS PHARMACEUTIQUES DERIVEES DE STEROIDES POUR LE TRAITEMENT DE TROUBLES ASSOCIES A DES PROCESSUS PATHOLOGIQUES DANS LES RADEAUX LIPIDIQUES
  申请人：JADOLABS GMBH

  公开号：WO2006002907A1

  公开（公告）日：2006-01-12

  The present invention relates to the use of specific steroid derivatives in the preparation of medicaments for the treatment or prevention and/or amelioration of disorders relating to pathological processes in lipid rafts.

  本发明涉及在制备用于治疗或预防和/或改善与脂质浮 rafts 中的病理过程相关的疾病的药物时使用特定类固醇衍生物。
• USE OF STEROID-DERIVED PHARMACEUTICAL COMPOSITIONS FOR TREATING DISORDERS RELATING TO PATHOLOGICAL PROCESSES IN LIPID RAFTS
  申请人：Jado Technologies GmbH

  公开号：EP1789056A1

  公开（公告）日：2007-05-30
• Steroid-Derived Pharmaceutical Compositions
  申请人：Braxmeier Tobias

  公开号：US20080255076A1

  公开（公告）日：2008-10-16

  The present invention relates to the use of specific steroid derivatives in the preparation of medicaments for the treatment or prevention and/or amelioration of disorders relating to pathological processes in lipid rafts.